Pharmacogenomics and Personalized Medicine - PubMed

Pharmacogenomics and Personalized Medicine - PubMed

Pharmacogenomics and Personalized Medicine

Erika Cecchin 1, Gabriele Stocco 2

Affiliations 

• PMID: 32580376
 
• DOI: 10.3390/genes11060679

Free article

Abstract

Pharmacogenomics is one of the emerging approaches to precision medicine, tailoring drug selection and dosing to the patient's genetic features. In recent years, several pharmacogenetic guidelines have been published by international scientific consortia, but the uptake in clinical practice is still poor. Many coordinated international efforts are ongoing in order to overcome the existing barriers to pharmacogenomic implementation. On the other hand, existing validated pharmacogenomic markers can explain only a minor part of the observed clinical variability in the therapeutic outcome. New investigational approaches are warranted, including the study of the pharmacogenomic role of the immune system genetics and of previously neglected rare genetic variants, reported to account for a large part of the inter-individual variability in drug metabolism. In this Special Issue, we collected a series of articles covering many aspects of pharmacogenomics. These include clinical implementation of pharmacogenomics in clinical practice, development of tools or infrastractures to support this process, research of new pharmacogenomics markers to increase drug efficacy and safety, and the impact of rare genetic variants in pharmacogenomics.

Keywords: human genetics; personalized medicine; pharmacogenomics; pharmacology.

Similar articles

• Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.

  Cecchin E, De Mattia E, Ecca F, Toffoli G.Drug Resist Updat. 2018 Jul;39:18-40. doi: 10.1016/j.drup.2018.07.001. Epub 2018 Jul 10.PMID: 30075835 Review.
• Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.

  Cecchin E, Roncato R, Guchelaar HJ, Toffoli G; Ubiquitous Pharmacogenomics Consortium.Curr Pharm Biotechnol. 2017;18(3):204-209. doi: 10.2174/1389201018666170103103619.PMID: 28044932 Review.
• Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.

  Arbitrio M, Di Martino MT, Scionti F, Barbieri V, Pensabene L, Tagliaferri P.High Throughput. 2018 Dec 18;7(4):40. doi: 10.3390/ht7040040.PMID: 30567415 Free PMC article. Review.
• The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children: pediatric pharmacogenomics working group.

  Kennedy MJ, Phan H, Benavides S, Potts A, Sorensen S.J Pediatr Pharmacol Ther. 2011 Apr;16(2):118-22. doi: 10.5863/1551-6776-16.2.118.PMID: 22477836 Free PMC article.
• Pharmacogenomics of chemotherapeutic susceptibility and toxicity.

  Moen EL, Godley LA, Zhang W, Dolan ME.Genome Med. 2012 Nov 30;4(11):90. doi: 10.1186/gm391. eCollection 2012.PMID: 23199206 Free PMC article. Review.